SK281052B6 - Derivát arylalkyltiadiazinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje a použitie - Google Patents

Derivát arylalkyltiadiazinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje a použitie Download PDF

Info

Publication number
SK281052B6
SK281052B6 SK123-96A SK12396A SK281052B6 SK 281052 B6 SK281052 B6 SK 281052B6 SK 12396 A SK12396 A SK 12396A SK 281052 B6 SK281052 B6 SK 281052B6
Authority
SK
Slovakia
Prior art keywords
dihydro
thiadiazin
ethyl
chloride
dimethoxyphenyl
Prior art date
Application number
SK123-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK12396A3 (en
Inventor
Rochus Jonas
Michael Wolf
Michael Klockow
Original Assignee
Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gesellschaft Mit Beschr�Nkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Publication of SK12396A3 publication Critical patent/SK12396A3/sk
Publication of SK281052B6 publication Critical patent/SK281052B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SK123-96A 1995-01-28 1996-01-26 Derivát arylalkyltiadiazinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje a použitie SK281052B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502699A DE19502699A1 (de) 1995-01-28 1995-01-28 Arylalkyl-thiadiazinone

Publications (2)

Publication Number Publication Date
SK12396A3 SK12396A3 (en) 1996-10-02
SK281052B6 true SK281052B6 (sk) 2000-11-07

Family

ID=7752553

Family Applications (1)

Application Number Title Priority Date Filing Date
SK123-96A SK281052B6 (sk) 1995-01-28 1996-01-26 Derivát arylalkyltiadiazinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje a použitie

Country Status (22)

Country Link
US (2) US5747489A (cs)
EP (1) EP0723962B1 (cs)
JP (1) JP3878237B2 (cs)
KR (1) KR100384726B1 (cs)
AT (1) ATE202775T1 (cs)
AU (1) AU705639B2 (cs)
CA (1) CA2168193C (cs)
CZ (1) CZ286635B6 (cs)
DE (2) DE19502699A1 (cs)
DK (1) DK0723962T3 (cs)
ES (1) ES2160184T3 (cs)
GR (1) GR3036343T3 (cs)
HU (1) HU219361B (cs)
NO (1) NO305835B1 (cs)
PL (1) PL184486B1 (cs)
PT (1) PT723962E (cs)
RU (1) RU2161613C2 (cs)
SI (1) SI0723962T1 (cs)
SK (1) SK281052B6 (cs)
TW (1) TW342389B (cs)
UA (1) UA42731C2 (cs)
ZA (1) ZA96630B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
HUP0303181A2 (hu) * 2001-02-12 2004-01-28 Merck Patent Gmbh. 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
CN1578665A (zh) * 2001-10-31 2005-02-09 默克专利股份公司 4型磷酸二脂酶抑制剂及其应用
WO2005075456A1 (en) 2004-02-04 2005-08-18 Altana Pharma Ag 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
US20080227790A1 (en) * 2004-02-04 2008-09-18 Altana Pharma Ag Pyridazinone Derivatives and their Use as Pde4 Inhibitors
DE102005055355A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate
DE102005055354A1 (de) * 2005-11-21 2007-10-31 Merck Patent Gmbh Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine
US8418387B2 (en) * 2009-11-13 2013-04-16 Manufacturing Resources International, Inc. Isolated access assembly for back-to-back electronic display and static display
RU2597764C2 (ru) * 2014-12-16 2016-09-20 Федеральное государственное автономное образовательное учреждение высшего образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" Применение соединений класса 1,3,4-тиадиазина в качестве средства коррекции экспериментального аллоксанового сахарного диабета
RU2659574C2 (ru) * 2016-12-27 2018-07-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) 6-(3,5-Дифенил-1,3,4-тиадиазол-2(3Н)-илиден)-2,4-дифенил-4Н-1,3,4-тиадиазин-5-он и способ его получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds
DE3719031A1 (de) * 1987-06-06 1988-12-22 Merck Patent Gmbh 5-(1,2,3,4-tetrahydrochinolyl)-3,6-dihydro-1,3,4-thiadiazin-2-one
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
SU1648949A1 (ru) * 1989-04-25 1991-05-15 Ленинградский Технологический Институт Им.Ленсовета Способ получени 2,4,5-замещенных 4Н-1,3,4-тиадиазинов
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone

Also Published As

Publication number Publication date
CA2168193A1 (en) 1996-07-29
AU4211196A (en) 1996-08-08
PL312489A1 (en) 1996-08-05
CZ286635B6 (cs) 2000-05-17
UA42731C2 (uk) 2001-11-15
GR3036343T3 (en) 2001-11-30
NO960352D0 (no) 1996-01-26
HU9503933D0 (en) 1996-03-28
DK0723962T3 (da) 2001-10-29
DE59607188D1 (de) 2001-08-09
HU219361B (en) 2001-03-28
SK12396A3 (en) 1996-10-02
EP0723962A1 (de) 1996-07-31
ZA96630B (en) 1996-08-15
EP0723962B1 (de) 2001-07-04
KR960029327A (ko) 1996-08-17
PL184486B1 (pl) 2002-11-29
NO960352L (no) 1996-07-29
TW342389B (en) 1998-10-11
ATE202775T1 (de) 2001-07-15
JP3878237B2 (ja) 2007-02-07
KR100384726B1 (ko) 2003-08-25
PT723962E (pt) 2001-10-31
AU705639B2 (en) 1999-05-27
DE19502699A1 (de) 1996-08-01
US6025354A (en) 2000-02-15
CA2168193C (en) 2006-08-15
SI0723962T1 (cs) 2001-12-31
RU2161613C2 (ru) 2001-01-10
HUT73981A (en) 1996-10-28
US5747489A (en) 1998-05-05
NO305835B1 (no) 1999-08-02
CZ25196A3 (en) 1996-08-14
ES2160184T3 (es) 2001-11-01
JPH08231522A (ja) 1996-09-10

Similar Documents

Publication Publication Date Title
US6531473B2 (en) Method of treatment using arylalkylpyridazinones
SK281474B6 (sk) Deriváty arylalkyldiazinónu, spôsob ich prípravy, farmaceutický prostriedok, ktorý ich obsahuje, a ich použitie
US5326770A (en) Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
EP0243018B1 (en) Thiolactam-n-acetic acid derivatives, their production and use
SK281052B6 (sk) Derivát arylalkyltiadiazinónu, spôsob jeho prípravy, farmaceutický prostriedok, ktorý ho obsahuje a použitie
US5332754A (en) Naphthyloxazolidone derivatives
JP2025510512A (ja) Lpa受容体活性と関連する状態の処置のための化合物および組成物
US5434149A (en) Thiadiazinones
PL208284B1 (pl) Pochodne benzo[g]chinoliny, kompozycje je zawierające oraz zastosowanie takich pochodnych
JPH04330078A (ja) 抗緑内障剤としての置換チエノ[2,3−b][1,4]チアジン−6−スルホンアミド類
US3773781A (en) 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates
US6117867A (en) Substituted 6-R-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetizing, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
PL165110B1 (pl) Sposób wytwarzania nowych zwiazków heterocyklicznych zawierajacych azot i siarke PL PL
SK512000A3 (en) Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists
US4780462A (en) Antihypertensive 1,5-benzothiazepine derivatives and compositions thereof
JPH02202857A (ja) アミノアルコキシベンゼン誘導体